Search

Your search keyword '"Casanova, Michela"' showing total 1,117 results

Search Constraints

Start Over You searched for: Author "Casanova, Michela" Remove constraint Author: "Casanova, Michela"
1,117 results on '"Casanova, Michela"'

Search Results

1. AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial

2. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART

3. A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

5. Secondary osteosarcoma: a challenge indeed

6. Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 study

7. Nasopharyngeal Carcinoma

8. Liver Tumors

11. How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment

12. Caring for children with cancer evacuated from Ukraine: The patients’ perception

13. Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis

14. Caring for children with cancer evacuated from Ukraine: the patients’ perception

16. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

17. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

21. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma

22. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

23. Local treatment in initially unresected non‐rhabdomyosarcoma soft‐tissue sarcomas of children and adolescents: A retrospective single‐center experience

25. PROLONGED COVID-19 INFECTION IN A CHILD WITH LYMPHOBLASTIC NON HODGKIN LYMPHOMA: WHICH IS THE BEST MANAGEMENT?

26. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

27. Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma

31. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

33. Supplementary Table S4 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

34. Data from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

35. Supplementary Figure S3 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

36. Supplementary Data S2 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

38. Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives

39. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

40. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients

42. Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

43. Regorafenib Plus Vincristine and Irinotecan in Pediatric Patients With Recurrent/Refractory Solid Tumors: An Innovative Therapies for Children With Cancer Study

45. Maintenance Chemotherapy for Patients with Rhabdomyosarcoma

47. Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

48. Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents

49. Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC).

50. Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (E p SSG) experience

Catalog

Books, media, physical & digital resources